| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 3, 2021Virtual Press Office and PR Newswire: General Trade show news
Geneos Therapeutics, a clinical stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer, announced today positive preliminary results of its...
-
Jun 3, 2021Virtual Press Office and PR Newswire: General Trade show news
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced presentations of data from the...
-
Jun 3, 2021Virtual Press Office and PR Newswire: General Trade show news
Leidos (NYSE: LDOS), a FORTUNE 500® science and technology company, will participate in the Stifel 2021 Virtual Cross Sector Insight Conference webcast. Chris Cage, Corporate Controller and...
-
Jun 3, 2021Virtual Press Office and PR Newswire: General Trade show news
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced...
-
Jun 3, 2021Virtual Press Office and PR Newswire: General Trade show news
MannKind Corporation (Nasdaq: MNKD), which focuses on the development of innovative medicines for patients with endocrine and orphan lung diseases, announced today that it will present a poster...
